YMAB icon

Y-mAbs Therapeutics
YMAB

Overview Fund Activity

85 hedge funds and large institutions have $95.4M invested in Y-mAbs Therapeutics in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
-6
Holders Change %
-6.59%
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
32
Reduced
27
Closed
19
Calls
$50K
Puts
$2K
Net Calls
+$48K
Net Calls Change
-$44K

Top Buyers

1
ACM
1
AIGH Capital Management
Maryland
$2.15M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$1.62M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$3.96M
4
Nuveen Asset Management
4
Nuveen Asset Management
Illinois
$1.67M
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$2M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$1.53M
2
Millennium Management
2
Millennium Management
New York
$3.12M
3
AG
3
Artal Group
Luxembourg
$0
4
BlackRock
4
BlackRock
New York
$11.8M
5
E
5
Ergoteles
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PMEF
101
Point72 Middle East FZE
United Arab Emirates
– -$14.6K -2,999 Closed
Zurich Cantonal Bank
102
Zurich Cantonal Bank
Switzerland
– -$8.27K -1,694 Closed
Canada Life
103
Canada Life
Manitoba, Canada
– -$7K -1,443 Closed
1 2 3 4
5